{"abdominal pain": 2.13, "anaphylactic reaction": 4.33, "anaphylactic shock": 11.62, "ankylosing spondylitis": 20.15, "arthritis": 5.22, "bronchospasm": 5.49, "chest discomfort": 5.49, "colitis ulcerative": 11.73, "condition aggravated": 2.21, "crohn's disease": 13.47, "drug hypersensitivity": 2.0, "drug ineffective": 4.07, "drug specific antibody present": 55.62, "dyspnoea": 4.95, "eczema": 4.52, "erythema": 11.05, "face oedema": 5.19, "feeling hot": 2.88, "flushing": 17.5, "frequent bowel movements": 10.05, "hot flush": 2.1, "hyperhidrosis": 2.47, "hypersensitivity": 6.0, "hypotension": 3.13, "infusion related reaction": 20.43, "laryngospasm": 39.69, "loss of therapeutic response": 142.73, "oropharyngeal discomfort": 9.48, "oxygen saturation decreased": 4.11, "product quality issue": 7.84, "product substitution issue": 101.58, "pruritus": 3.31, "psoriasis": 15.18, "psoriasis area severity index increased": 401.55, "rash": 2.95, "rash erythematous": 2.67, "rectal haemorrhage": 5.53, "skin reaction": 4.18, "therapeutic product effect decreased": 4.17, "therapy non-responder": 13.1, "throat tightness": 6.09, "urticaria": 5.93}